Fe/sub 64/Co/sub 21/B/sub 15/
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... of Fe 3 O 4 , Dex/Fe 3 O 4 , and Bis/Dex/Fe 3 O 4 was verified by XRD (Figure ...standard Fe 3 O 4 pattern published by ...Bis/Dex/ Fe 3 O 4 was smaller than that of Fe 3 O 4 ...
12
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
... The in vitro bioassay, as shown in Figure 9, tells us that, after 72 hours of treatment, neither gallic acid nor FCG was toxic to a normal human fibroblast (3T3) cell line tested using various doses (0.47, 0.94, 1.88, ...
12
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... to Fe 3 O 4 NPs (100 µ g/mL), there was a progressive decrease in the activity of MEP-induced channels, which occurred at the level of hyperpolarizing potentials ranging between − 80 and − 200 ...of Fe 3 O ...
10
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... ± 15 µ g/g at six hours after dosing, and then decreased ...of Fe 3 O 4 MNPs were higher in the liver and spleen than those in other ...for Fe 3 O 4 ...
6
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... All animals were kept in stress-free, hygienic, and animal- friendly conditions (relative humidity 60% ± 10%, room tem- perature 20 ° C ± 2 ° C, and 12-hour light/dark cycle). Food and water were available ad libitum. ...
15
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... for Fe@Si NP intravenous adminis- tration: control group, low-dose 10 nm Fe@Si NP-exposure group (10L), low-dose 20 nm Fe@Si NP-exposure group (20L), high-dose 20 nm Fe@Si NP-exposure group ...
16
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
... ± 15% humidity, and 12 h light/dark cycle) and had free access to water and ...Then, Fe 3 O 4 -PLGA or Fe 3 O 4 -PLGA-cRGD NPs at a final dosage of 1 mg lyophilized powder dissolving 1 mL phosphate- ...
14
The changes of T lymphocytes and cytokines in ICR mice fed with Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... cells/mL with RPMI-1640. The adjusted cells were placed in a 96-well microtiter plate in 200 µ L aliquots and cultured in the presence of T-lymphocytes mitogen (5 µ g/mL Con- canavalin A [ConA]) (Sigma Chemical ...
6
Preparation and in vitro evaluation of doxorubicin-loaded Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles modified with biocompatible copolymers
... Figure 15. In the current work, the MTT assay showed that Fe 3 O 4 -PLGA-PEG 2000 -doxorubicin has dose-dependent and time-dependent cytotoxicity against the A549 lung can- cer cell line (IC 50 ...that ...
16
Multifunctional magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
... Group B, treated with DNR 1 mg/kg; Group C, treated with 5-BrTet 1 mg/kg and DNR 1 mg/kg; Group D, treated with Fe 3 O 4 -MNP 22 mg/kg; and Group E, treated with Fe 3 O 4 -MNP- DNR-5-BrTet 24 mg/kg, ...
9
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... Elemental analysis was performed using scanning electron microscopy-energy dispersive x-ray spectroscopy (SEM-EDS, EDAX 9100; EDAX International, Prairie View, IL). X-ray diffraction data were collected using an XD-D1 ...
10
Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells
... Based on the results of cytotoxicity assay, the best combina- tion condition of ART with MNPs-Fe 3 O 4 (100:1 M/M) was used to measure the apoptosis rate. Briefly, after being treated with ART, MNPs-Fe 3 O ...
8
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... Mice were randomly assigned to one of four groups (n = 10 per group). The doses of 5.14 mg/kg (low dose group), 20.7 mg/kg (medium dose group), and 51.4 mg/kg (high dose group) Fe 3 O 4 -MNPs, were dissolved in ...
7
Fe and Co doped (Ba, Ca)TiO<sub>3</sub> Perovskite as Potential Electrocatalysts for Glutamate Sensing
... Through enhancement of electrocatalysis in perovskite materials, their electrochemical sensing efficacy is achieved. With extensive concern regarding food quality and safety, development of food sensors becomes ...
14
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... Nanomaterials interact directly with tissues and cells after entering the body. Therefore, the most basic criteria for its clinical application are safety and good biocompatibility, which is also important to the ...
6
Synergistic effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> with gambogic acid on apoptosis of K562 leukemia cells
... for 15 minutes, stained with fluorochrome dye DAPI (Santa Cruz Biotechnologies), and then observed under a fluorescence microscope (IX51; Olympus, Tokyo, Japan) with a peak excitation wave length of 340 ...
9
Magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> enhance docetaxel-induced prostate cancer cell death
... were incubated with MgNPs-Fe 3 O 4 (1 µ g/mL, 10 µ g/mL, or 100 µ g/mL) for 24 hours in the absence or presence of N-acetylcysteine (NAC; 10 mM) (Sigma-Aldrich Co); NAC was added 3 hours before treatment ...
10
Magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells
... The combination of MNP-Fe 3 O 4 with different chemo- therapeutics may provide new clinical options in the treatment of lymphoma. However, few in vitro data are available for the combination of MNP-Fe 3 O 4 ...
6
The Combination of Calcium Oxide and Cu/ZrO<sub>2</sub> Catalyst and their Selective Products for CO<sub>2</sub> Hydrogenation
... The increasing rate of energy consumption is one of the severe impacts on environmental topics nowadays because of large population growth and their demand for sustenance, transportation and novel technology which are an ...
10
<p>Transcutaneous CO<sub>2</sub> versus end-tidal CO<sub>2</sub> in neonates and infants undergoing surgery: a prospective study</p>
... accepted graphical technique plots the mean of the two measures versus the difference of the two measures with 95% limits of agreement. If the two measures agree perfectly, all differences will be zero. The difference of ...
8